Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 146 | 2 | 140 | −4 |
| Shares | 27.3M | 16.9K | 27.9M | +679.9K (+2.5%) |
| Value | $549.6M | $341.0K | $530.8M | −$18.5M (−3.4%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 79,603 | $1.51M | 0.01% |
| Guggenheim Capital LLC | 37,056 | $704.0K | 0.00% |
| PDT Partners, LLC | 27,537 | $523.0K | 0.04% |
| Maryland State Retirement & Pension System | 14,542 | $281.0K | 0.01% |
| Campbell & CO Investment Adviser LLC | 10,600 | $202.0K | 0.07% |
| First Mercantile Trust Co | 5,533 | $105.0K | 0.01% |
| Point72 Hong Kong Ltd | 139 | $3.00K | 0.00% |
| Parallel Advisors, LLC | 109 | $2.00K | 0.00% |
| Fifth Third Bancorp | 75 | $1.00K | 0.00% |
| Carroll Financial Associates, Inc. | 85 | $1.00K | 0.00% |
| Meridian Wealth Partners, LLC | 56 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Exchange Traded Concepts, LLC | 57,851 | $1.17M |
| Squarepoint Ops LLC | 40,760 | $822.0K |
| D. E. Shaw & Co., Inc. | 35,699 | $720.0K |
| Citadel Advisors LLC | 24,373 | $492.0K |
| 6 Meridian | 20,838 | $420.0K |
| Engineers Gate Manager LP | 17,184 | $346.0K |
| Aigen Investment Management, LP | 12,390 | $250.0K |
| Veriti Management LLC | 11,949 | $241.0K |
| Panagora Asset Management Inc | 7,916 | $160.0K |
| Lazard Asset Management LLC | 3,479 | $70.0K |
| FORA Capital, LLC | 1,338 | $27.0K |
| FMR LLC | 125 | $3.00K |
| Massmutual Trust Co FSB | 129 | $3.00K |
| Group One Trading, L.P. | 100 | $2.00K |
| Parkside Financial Bank & Trust | 8 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 15,900 | $321.0K |
| Pinnacle Wealth Advisors | 1,000 | $20.0K |